STOCK TITAN

[8-K] Krispy Kreme, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Claritev Corp. (NYSE: CTEV) – Q2 2025 10-Q highlights

  • Revenue rose 3.5 % YoY to $241.6 m (H1 +1 % to $472.9 m) driven mainly by Network-Based and Payment & Revenue Integrity services; PSAV still >82 % of mix.
  • Operating swing to profit: Q2 operating income $16.6 m versus a $523.9 m loss last year when a $553.7 m goodwill charge was recorded. No impairments in 2025 to date.
  • Net loss narrowed to $62.6 m (-$3.81/sh) from $576.7 m (-$35.78/sh); H1 loss cut to $134.0 m from $1.12 bn.
  • Cash strengthened to $56.4 m from $16.8 m at 12/31/24, helped by a $130 m draw on the new 2025 revolving credit facility; operating cash flow fell to $31.2 m (-54 %).
  • Leverage remains high: total debt $4.59 bn (net increase after January refinancing); quarterly interest expense up 23 % to $99.7 m. Shareholders’ equity turned negative (-$39.9 m).
  • Refinancing (Jan-25) exchanged legacy notes/loans into staggered First-Out, Second-Out and Third-Out first-lien instruments maturing 2030-31 and added a $350 m revolver; $7.9 m YTD transaction costs booked.
  • Company remains compliant with covenants; $263.6 m revolver availability at quarter-end.
  • Name & ticker change from MultiPlan/MPLN to Claritev/CTEV became effective Feb 28 2025.

Key ratios: Q2 gross margin 74.8 % (flat), adj. operating margin 6.9 %, interest coverage <0.3×, YoY cash conversion 13 %.

Claritev Corp. (NYSE: CTEV) – Principali dati del 10-Q del secondo trimestre 2025

  • Ricavi in crescita del 3,5% su base annua, raggiungendo 241,6 milioni di dollari (H1 +1% a 472,9 milioni), trainati principalmente dai servizi Network-Based e Payment & Revenue Integrity; PSAV rappresenta ancora oltre l'82% del mix.
  • Passaggio a utile operativo: utile operativo del secondo trimestre di 16,6 milioni di dollari rispetto a una perdita di 523,9 milioni dello scorso anno, quando è stata registrata una svalutazione di avviamento di 553,7 milioni; nessuna svalutazione registrata nel 2025 finora.
  • Perdita netta ridotta a 62,6 milioni di dollari (-3,81 $/azione) da 576,7 milioni (-35,78 $/azione); perdita nel primo semestre ridotta a 134,0 milioni da 1,12 miliardi.
  • Liquidità rafforzata a 56,4 milioni da 16,8 milioni al 31/12/24, favorita da un utilizzo di 130 milioni sulla nuova linea di credito revolving 2025; flusso di cassa operativo sceso a 31,2 milioni (-54%).
  • Leva finanziaria ancora elevata: debito totale a 4,59 miliardi (aumento netto dopo rifinanziamento di gennaio); spese per interessi trimestrali aumentate del 23% a 99,7 milioni. Patrimonio netto negativo (-39,9 milioni).
  • Rifinanziamento (gennaio 2025) ha convertito le note/prestiti precedenti in strumenti first-lien a scadenza 2030-31, suddivisi in First-Out, Second-Out e Third-Out, e ha aggiunto una linea revolving da 350 milioni; costi di transazione di 7,9 milioni contabilizzati da inizio anno.
  • L’azienda rimane in regola con i covenant; disponibilità sulla linea revolving di 263,6 milioni a fine trimestre.
  • Cambio di nome e ticker da MultiPlan/MPLN a Claritev/CTEV effettivo dal 28 febbraio 2025.

Indicatori chiave: margine lordo Q2 74,8% (stabile), margine operativo rettificato 6,9%, copertura degli interessi <0,3×, conversione di cassa YoY 13%.

Claritev Corp. (NYSE: CTEV) – Destacados del 10-Q del segundo trimestre 2025

  • Los ingresos aumentaron un 3,5% interanual hasta 241,6 millones de dólares (primer semestre +1% a 472,9 millones), impulsados principalmente por los servicios Network-Based y Payment & Revenue Integrity; PSAV sigue representando más del 82% de la mezcla.
  • Giro a beneficio operativo: ingreso operativo del segundo trimestre de 16,6 millones frente a una pérdida de 523,9 millones el año pasado, cuando se registró un cargo por deterioro de goodwill de 553,7 millones; sin deterioros en 2025 hasta la fecha.
  • Pérdida neta reducida a 62,6 millones (-3,81 $/acción) desde 576,7 millones (-35,78 $/acción); pérdida en el primer semestre reducida a 134,0 millones desde 1,12 mil millones.
  • Liquidez fortalecida a 56,4 millones desde 16,8 millones al 31/12/24, ayudada por un uso de 130 millones en la nueva línea de crédito revolvente 2025; flujo de caja operativo cayó a 31,2 millones (-54%).
  • Apalancamiento aún alto: deuda total de 4,59 mil millones (aumento neto tras refinanciamiento de enero); gastos por intereses trimestrales aumentaron un 23% a 99,7 millones. Patrimonio neto negativo (-39,9 millones).
  • Refinanciamiento (enero 2025) convirtió notas/préstamos anteriores en instrumentos first-lien escalonados First-Out, Second-Out y Third-Out con vencimiento 2030-31 y añadió una línea revolvente de 350 millones; costos de transacción de 7,9 millones registrados en lo que va del año.
  • La compañía sigue cumpliendo con los convenios; disponibilidad en la línea revolvente de 263,6 millones al cierre del trimestre.
  • Cambio de nombre y ticker de MultiPlan/MPLN a Claritev/CTEV efectivo desde el 28 de febrero de 2025.

Ratios clave: margen bruto Q2 74,8% (estable), margen operativo ajustado 6,9%, cobertura de intereses <0,3×, conversión de caja interanual 13%.

Claritev Corp. (NYSE: CTEV) – 2025년 2분기 10-Q 주요 내용

  • 매출이 전년 대비 3.5% 증가하여 2억 4,160만 달러(상반기 +1%로 4억 7,290만 달러)에 달했으며, 주로 네트워크 기반 및 결제 및 수익 무결성 서비스가 견인; PSAV는 여전히 전체 매출의 82% 이상 차지.
  • 영업이익 흑자 전환: 2분기 영업이익 1,660만 달러로, 전년 동기 5억 2,390만 달러 손실 대비 개선, 당시 5억 5,370만 달러의 영업권 손상차손 기록. 2025년 현재까지 손상차손 없음.
  • 순손실 축소 6,260만 달러(-주당 3.81달러)로, 전년 5억 7,670만 달러(-주당 35.78달러) 대비 감소; 상반기 손실은 1억 3,400만 달러로 11억 2천만 달러에서 축소됨.
  • 현금성 자산 강화 5,640만 달러로 2024년 12월 31일의 1,680만 달러에서 증가, 2025년 신규 리볼빙 신용시설에서 1억 3천만 달러 인출에 힘입음; 영업현금흐름은 3,120만 달러로 54% 감소.
  • 레버리지 여전히 높음: 총 부채 45억 9천만 달러(1월 재융자 후 순증가); 분기별 이자 비용 23% 증가하여 9,970만 달러. 주주지분은 마이너스(-3,990만 달러) 전환.
  • 재융자 (2025년 1월) 기존 채권/대출을 2030-31년 만기인 First-Out, Second-Out, Third-Out 선순위 담보부 증권으로 교환하고 3억 5천만 달러 리볼버 추가; 연초 이후 거래 비용 790만 달러 계상.
  • 회사는 약정 준수 상태 유지; 분기 말 리볼버 가용액 2억 6,360만 달러.
  • 회사명 및 티커 변경 MultiPlan/MPLN에서 Claritev/CTEV로 2025년 2월 28일부로 시행.

주요 지표: 2분기 총 마진 74.8% (변동 없음), 조정 영업이익률 6.9%, 이자보상배율 <0.3배, 전년 대비 현금 전환율 13%.

Claritev Corp. (NYSE: CTEV) – Points clés du 10-Q du T2 2025

  • Chiffre d'affaires en hausse de 3,5 % en glissement annuel à 241,6 M$ (S1 +1 % à 472,9 M$), principalement porté par les services Network-Based et Payment & Revenue Integrity ; PSAV représente toujours plus de 82 % du mix.
  • Retour à un résultat opérationnel positif : résultat opérationnel du T2 à 16,6 M$ contre une perte de 523,9 M$ l’an dernier, liée à une charge de goodwill de 553,7 M$ ; aucune dépréciation enregistrée en 2025 à ce jour.
  • Perte nette réduite à 62,6 M$ (-3,81 $/action) contre 576,7 M$ (-35,78 $/action) ; perte semestrielle réduite à 134,0 M$ contre 1,12 Md$.
  • Trésorerie renforcée à 56,4 M$ contre 16,8 M$ au 31/12/24, soutenue par un tirage de 130 M$ sur la nouvelle ligne de crédit renouvelable 2025 ; flux de trésorerie opérationnel en baisse à 31,2 M$ (-54 %).
  • Endettement toujours élevé : dette totale de 4,59 Md$ (augmentation nette après refinancement de janvier) ; charges d’intérêts trimestrielles en hausse de 23 % à 99,7 M$. Capitaux propres devenus négatifs (-39,9 M$).
  • Refinancement (janv. 2025) a converti les anciennes notes/prêts en instruments first-lien étagés First-Out, Second-Out et Third-Out échéant en 2030-31 et ajouté une ligne renouvelable de 350 M$ ; coûts de transaction de 7,9 M$ comptabilisés depuis le début de l’année.
  • L’entreprise reste conforme aux covenants ; disponibilité de la ligne renouvelable à 263,6 M$ à la fin du trimestre.
  • Changement de nom et de ticker de MultiPlan/MPLN à Claritev/CTEV effectif au 28 février 2025.

Ratios clés : marge brute T2 74,8 % (stable), marge opérationnelle ajustée 6,9 %, couverture des intérêts <0,3×, conversion de trésorerie annuelle 13 %.

Claritev Corp. (NYSE: CTEV) – Highlights des 10-Q für Q2 2025

  • Umsatz stieg um 3,5% im Jahresvergleich auf 241,6 Mio. USD (H1 +1 % auf 472,9 Mio.), hauptsächlich getrieben durch Network-Based und Payment & Revenue Integrity Services; PSAV bleibt mit über 82 % der Mischung dominierend.
  • Operativer Turnaround: Operatives Ergebnis im Q2 von 16,6 Mio. USD gegenüber einem Verlust von 523,9 Mio. USD im Vorjahr, als eine Goodwill-Abschreibung von 553,7 Mio. USD verbucht wurde. Bis dato keine Wertminderungen in 2025.
  • Nettoverlust verringert auf 62,6 Mio. USD (-3,81 $/Aktie) von 576,7 Mio. USD (-35,78 $/Aktie); Halbjahresverlust auf 134,0 Mio. USD von 1,12 Mrd. USD reduziert.
  • Barmittel gestärkt auf 56,4 Mio. USD von 16,8 Mio. USD zum 31.12.24, unterstützt durch eine Inanspruchnahme von 130 Mio. USD aus der neuen revolvierenden Kreditlinie 2025; operativer Cashflow fiel auf 31,2 Mio. USD (-54 %).
  • Verschuldung bleibt hoch: Gesamtschulden 4,59 Mrd. USD (Nettoanstieg nach Refinanzierung im Januar); Zinsaufwand im Quartal um 23 % auf 99,7 Mio. USD gestiegen. Eigenkapital wurde negativ (-39,9 Mio. USD).
  • Refinanzierung (Jan-25) tauschte Altanleihen/-kredite in gestaffelte First-Out, Second-Out und Third-Out First-Lien-Instrumente mit Fälligkeiten 2030-31 um und fügte eine revolvierende Kreditlinie von 350 Mio. USD hinzu; bisher 7,9 Mio. USD Transaktionskosten im Jahr verbucht.
  • Das Unternehmen bleibt konform mit den Covenants; revolvierende Kreditlinie mit 263,6 Mio. USD Verfügbarkeit zum Quartalsende.
  • Name und Tickeränderung von MultiPlan/MPLN zu Claritev/CTEV zum 28. Februar 2025 wirksam.

Wichtige Kennzahlen: Bruttomarge Q2 74,8 % (stabil), bereinigte operative Marge 6,9 %, Zinsdeckungsgrad <0,3×, Cash Conversion YoY 13 %.

Positive
  • Revenue growth of 3.5 % YoY and 1 % YTD after several weak quarters
  • Return to operating profit with $16.6 m income versus large prior-year loss
  • No impairment charges recorded in 2025, stabilising book value
  • Cash balance up 235 % since year-end, aided by new revolver
  • Extended debt maturities to 2030-31, reducing near-term refinancing risk
Negative
  • Continued net losses; Q2 loss $62.6 m, H1 loss $134 m
  • High leverage: $4.6 bn debt, net debt/EBITDA >9×, and rising interest expense
  • Shareholders’ equity negative (-$39.9 m) after six-month deficit
  • Operating cash flow halved to $31.2 m while capex outflows rose
  • Ongoing antitrust litigation and potential covenant pressure if revolver drawn further

Insights

TL;DR – Revenue and margins improve, but leverage and negative equity limit upside.

The absence of 2024-type impairment charges reveals Claritev’s underlying operations: mid-single-digit top-line growth and a mid-70 % gross margin. However, interest consumed 62 % of gross profit, keeping the firm in loss territory. The January refinancing extends maturities and boosts liquidity, yet at the price of higher secured debt and cash interest. Net debt/CY EBITDA remains >9×, leaving little headroom should volumes soften. Still, cash grew $39 m YTD and the company stays covenant-compliant, suggesting near-term default risk is low. Investors will watch for sustained revenue acceleration or cost saves to lift EBITDA and offset rising interest.

TL;DR – High leverage and negative equity keep credit risk elevated.

Claritev’s $4.6 bn debt stack—now mostly first-lien—crowds the capital structure. Shareholders’ equity flipped negative; any new impairment or rate spike could breach the 2.5× first-out leverage test once revolver usage exceeds 40 % of capacity. Interest expense already up 23 % YoY and SOFR hedges cover only $800 m until Aug-26. While Q2 cash improved, FCF is thin after $63 m capex. Litigation exposure (antitrust MDL) and the July OBBBA tax law’s still-unknown effect add uncertainty. Overall risk skewed negative until leverage is reduced.

Claritev Corp. (NYSE: CTEV) – Principali dati del 10-Q del secondo trimestre 2025

  • Ricavi in crescita del 3,5% su base annua, raggiungendo 241,6 milioni di dollari (H1 +1% a 472,9 milioni), trainati principalmente dai servizi Network-Based e Payment & Revenue Integrity; PSAV rappresenta ancora oltre l'82% del mix.
  • Passaggio a utile operativo: utile operativo del secondo trimestre di 16,6 milioni di dollari rispetto a una perdita di 523,9 milioni dello scorso anno, quando è stata registrata una svalutazione di avviamento di 553,7 milioni; nessuna svalutazione registrata nel 2025 finora.
  • Perdita netta ridotta a 62,6 milioni di dollari (-3,81 $/azione) da 576,7 milioni (-35,78 $/azione); perdita nel primo semestre ridotta a 134,0 milioni da 1,12 miliardi.
  • Liquidità rafforzata a 56,4 milioni da 16,8 milioni al 31/12/24, favorita da un utilizzo di 130 milioni sulla nuova linea di credito revolving 2025; flusso di cassa operativo sceso a 31,2 milioni (-54%).
  • Leva finanziaria ancora elevata: debito totale a 4,59 miliardi (aumento netto dopo rifinanziamento di gennaio); spese per interessi trimestrali aumentate del 23% a 99,7 milioni. Patrimonio netto negativo (-39,9 milioni).
  • Rifinanziamento (gennaio 2025) ha convertito le note/prestiti precedenti in strumenti first-lien a scadenza 2030-31, suddivisi in First-Out, Second-Out e Third-Out, e ha aggiunto una linea revolving da 350 milioni; costi di transazione di 7,9 milioni contabilizzati da inizio anno.
  • L’azienda rimane in regola con i covenant; disponibilità sulla linea revolving di 263,6 milioni a fine trimestre.
  • Cambio di nome e ticker da MultiPlan/MPLN a Claritev/CTEV effettivo dal 28 febbraio 2025.

Indicatori chiave: margine lordo Q2 74,8% (stabile), margine operativo rettificato 6,9%, copertura degli interessi <0,3×, conversione di cassa YoY 13%.

Claritev Corp. (NYSE: CTEV) – Destacados del 10-Q del segundo trimestre 2025

  • Los ingresos aumentaron un 3,5% interanual hasta 241,6 millones de dólares (primer semestre +1% a 472,9 millones), impulsados principalmente por los servicios Network-Based y Payment & Revenue Integrity; PSAV sigue representando más del 82% de la mezcla.
  • Giro a beneficio operativo: ingreso operativo del segundo trimestre de 16,6 millones frente a una pérdida de 523,9 millones el año pasado, cuando se registró un cargo por deterioro de goodwill de 553,7 millones; sin deterioros en 2025 hasta la fecha.
  • Pérdida neta reducida a 62,6 millones (-3,81 $/acción) desde 576,7 millones (-35,78 $/acción); pérdida en el primer semestre reducida a 134,0 millones desde 1,12 mil millones.
  • Liquidez fortalecida a 56,4 millones desde 16,8 millones al 31/12/24, ayudada por un uso de 130 millones en la nueva línea de crédito revolvente 2025; flujo de caja operativo cayó a 31,2 millones (-54%).
  • Apalancamiento aún alto: deuda total de 4,59 mil millones (aumento neto tras refinanciamiento de enero); gastos por intereses trimestrales aumentaron un 23% a 99,7 millones. Patrimonio neto negativo (-39,9 millones).
  • Refinanciamiento (enero 2025) convirtió notas/préstamos anteriores en instrumentos first-lien escalonados First-Out, Second-Out y Third-Out con vencimiento 2030-31 y añadió una línea revolvente de 350 millones; costos de transacción de 7,9 millones registrados en lo que va del año.
  • La compañía sigue cumpliendo con los convenios; disponibilidad en la línea revolvente de 263,6 millones al cierre del trimestre.
  • Cambio de nombre y ticker de MultiPlan/MPLN a Claritev/CTEV efectivo desde el 28 de febrero de 2025.

Ratios clave: margen bruto Q2 74,8% (estable), margen operativo ajustado 6,9%, cobertura de intereses <0,3×, conversión de caja interanual 13%.

Claritev Corp. (NYSE: CTEV) – 2025년 2분기 10-Q 주요 내용

  • 매출이 전년 대비 3.5% 증가하여 2억 4,160만 달러(상반기 +1%로 4억 7,290만 달러)에 달했으며, 주로 네트워크 기반 및 결제 및 수익 무결성 서비스가 견인; PSAV는 여전히 전체 매출의 82% 이상 차지.
  • 영업이익 흑자 전환: 2분기 영업이익 1,660만 달러로, 전년 동기 5억 2,390만 달러 손실 대비 개선, 당시 5억 5,370만 달러의 영업권 손상차손 기록. 2025년 현재까지 손상차손 없음.
  • 순손실 축소 6,260만 달러(-주당 3.81달러)로, 전년 5억 7,670만 달러(-주당 35.78달러) 대비 감소; 상반기 손실은 1억 3,400만 달러로 11억 2천만 달러에서 축소됨.
  • 현금성 자산 강화 5,640만 달러로 2024년 12월 31일의 1,680만 달러에서 증가, 2025년 신규 리볼빙 신용시설에서 1억 3천만 달러 인출에 힘입음; 영업현금흐름은 3,120만 달러로 54% 감소.
  • 레버리지 여전히 높음: 총 부채 45억 9천만 달러(1월 재융자 후 순증가); 분기별 이자 비용 23% 증가하여 9,970만 달러. 주주지분은 마이너스(-3,990만 달러) 전환.
  • 재융자 (2025년 1월) 기존 채권/대출을 2030-31년 만기인 First-Out, Second-Out, Third-Out 선순위 담보부 증권으로 교환하고 3억 5천만 달러 리볼버 추가; 연초 이후 거래 비용 790만 달러 계상.
  • 회사는 약정 준수 상태 유지; 분기 말 리볼버 가용액 2억 6,360만 달러.
  • 회사명 및 티커 변경 MultiPlan/MPLN에서 Claritev/CTEV로 2025년 2월 28일부로 시행.

주요 지표: 2분기 총 마진 74.8% (변동 없음), 조정 영업이익률 6.9%, 이자보상배율 <0.3배, 전년 대비 현금 전환율 13%.

Claritev Corp. (NYSE: CTEV) – Points clés du 10-Q du T2 2025

  • Chiffre d'affaires en hausse de 3,5 % en glissement annuel à 241,6 M$ (S1 +1 % à 472,9 M$), principalement porté par les services Network-Based et Payment & Revenue Integrity ; PSAV représente toujours plus de 82 % du mix.
  • Retour à un résultat opérationnel positif : résultat opérationnel du T2 à 16,6 M$ contre une perte de 523,9 M$ l’an dernier, liée à une charge de goodwill de 553,7 M$ ; aucune dépréciation enregistrée en 2025 à ce jour.
  • Perte nette réduite à 62,6 M$ (-3,81 $/action) contre 576,7 M$ (-35,78 $/action) ; perte semestrielle réduite à 134,0 M$ contre 1,12 Md$.
  • Trésorerie renforcée à 56,4 M$ contre 16,8 M$ au 31/12/24, soutenue par un tirage de 130 M$ sur la nouvelle ligne de crédit renouvelable 2025 ; flux de trésorerie opérationnel en baisse à 31,2 M$ (-54 %).
  • Endettement toujours élevé : dette totale de 4,59 Md$ (augmentation nette après refinancement de janvier) ; charges d’intérêts trimestrielles en hausse de 23 % à 99,7 M$. Capitaux propres devenus négatifs (-39,9 M$).
  • Refinancement (janv. 2025) a converti les anciennes notes/prêts en instruments first-lien étagés First-Out, Second-Out et Third-Out échéant en 2030-31 et ajouté une ligne renouvelable de 350 M$ ; coûts de transaction de 7,9 M$ comptabilisés depuis le début de l’année.
  • L’entreprise reste conforme aux covenants ; disponibilité de la ligne renouvelable à 263,6 M$ à la fin du trimestre.
  • Changement de nom et de ticker de MultiPlan/MPLN à Claritev/CTEV effectif au 28 février 2025.

Ratios clés : marge brute T2 74,8 % (stable), marge opérationnelle ajustée 6,9 %, couverture des intérêts <0,3×, conversion de trésorerie annuelle 13 %.

Claritev Corp. (NYSE: CTEV) – Highlights des 10-Q für Q2 2025

  • Umsatz stieg um 3,5% im Jahresvergleich auf 241,6 Mio. USD (H1 +1 % auf 472,9 Mio.), hauptsächlich getrieben durch Network-Based und Payment & Revenue Integrity Services; PSAV bleibt mit über 82 % der Mischung dominierend.
  • Operativer Turnaround: Operatives Ergebnis im Q2 von 16,6 Mio. USD gegenüber einem Verlust von 523,9 Mio. USD im Vorjahr, als eine Goodwill-Abschreibung von 553,7 Mio. USD verbucht wurde. Bis dato keine Wertminderungen in 2025.
  • Nettoverlust verringert auf 62,6 Mio. USD (-3,81 $/Aktie) von 576,7 Mio. USD (-35,78 $/Aktie); Halbjahresverlust auf 134,0 Mio. USD von 1,12 Mrd. USD reduziert.
  • Barmittel gestärkt auf 56,4 Mio. USD von 16,8 Mio. USD zum 31.12.24, unterstützt durch eine Inanspruchnahme von 130 Mio. USD aus der neuen revolvierenden Kreditlinie 2025; operativer Cashflow fiel auf 31,2 Mio. USD (-54 %).
  • Verschuldung bleibt hoch: Gesamtschulden 4,59 Mrd. USD (Nettoanstieg nach Refinanzierung im Januar); Zinsaufwand im Quartal um 23 % auf 99,7 Mio. USD gestiegen. Eigenkapital wurde negativ (-39,9 Mio. USD).
  • Refinanzierung (Jan-25) tauschte Altanleihen/-kredite in gestaffelte First-Out, Second-Out und Third-Out First-Lien-Instrumente mit Fälligkeiten 2030-31 um und fügte eine revolvierende Kreditlinie von 350 Mio. USD hinzu; bisher 7,9 Mio. USD Transaktionskosten im Jahr verbucht.
  • Das Unternehmen bleibt konform mit den Covenants; revolvierende Kreditlinie mit 263,6 Mio. USD Verfügbarkeit zum Quartalsende.
  • Name und Tickeränderung von MultiPlan/MPLN zu Claritev/CTEV zum 28. Februar 2025 wirksam.

Wichtige Kennzahlen: Bruttomarge Q2 74,8 % (stabil), bereinigte operative Marge 6,9 %, Zinsdeckungsgrad <0,3×, Cash Conversion YoY 13 %.

0001857154false00018571542025-08-072025-08-07


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________

FORM 8-K
_________________________

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

August 7, 2025
Date of Report (Date of earliest event reported)
_________________________

Image_0.jpg
Krispy Kreme, Inc.
(Exact name of registrant as specified in its charter)
_________________________

Delaware001-4057337-1701311
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
2116 Hawkins Street, Suite 101, Charlotte, North Carolina 28203
(Address of principal executive offices)

(800) 457-4779
(Registrant’s telephone number, including area code)

N/A
(Former name or former address, if changed since last report)
_________________________

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered
Common stock, $0.01 par value per share
DNUT
NASDAQ Global Select Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




Item 2.02. Results of Operations and Financial Condition.
On August 7, 2025, the Company issued a press release announcing the Company's financial results for the second quarter ended June 29, 2025. A copy of such press release is attached as Exhibit 99.1 hereto and incorporated herein by reference.
The information contained in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
Exhibit No.Description
99.1
Press Release issued by Krispy Kreme, Inc. dated August 7, 2025




SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

KRISPY KREME, INC.

Dated: August 7, 2025

By:    /s/ Raphael Duvivier
Name:Raphael Duvivier
Title:Chief Financial Officer

FAQ

How did Claritev (CTEV) perform financially in Q2 2025?

Revenue grew 3.5 % to $241.6 m; operating income was $16.6 m, but net loss remained $62.6 m (-$3.81/sh).

What is Claritev’s current debt load after the refinancing?

Total debt is $4.59 bn with new first-lien tranches maturing 2030-31 and $80 m drawn on a $350 m revolver.

Did Claritev record any impairment charges in 2025?

No. Unlike 2024, the company booked no goodwill or intangible impairments in H1 2025.

Is Claritev meeting its loan covenants?

Yes. Management states it is in compliance and had $263.6 m revolver availability at 30 Jun 2025.

Why did shareholders’ equity turn negative?

Accumulated deficits and transaction costs pushed equity to -$39.9 m despite additional paid-in capital.

What impact did the January 2025 refinancing have on interest costs?

Quarterly interest expense rose 23 % YoY to $99.7 m due to higher secured debt balances.
Krispy Kreme, Inc.

NASDAQ:DNUT

DNUT Rankings

DNUT Latest News

DNUT Latest SEC Filings

DNUT Stock Data

621.71M
76.30M
54.61%
52.66%
13.87%
Grocery Stores
Retail-food Stores
Link
United States
CHARLOTTE